bafilomycin-a and Lymphoma

bafilomycin-a has been researched along with Lymphoma* in 1 studies

Other Studies

1 other study(ies) available for bafilomycin-a and Lymphoma

ArticleYear
Immunosuppressive effects of the macrolide antibiotic bafilomycin towards lymphocytes and lymphoid cell lines.
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:8

    The effects of bafilomycin macrolide antibiotics on primary lymphocytes and on tumor cell lines were investigated. Bafilomycin A markedly suppressed DNA, RNA, and protein synthesis in splenocyte cultures of several inbred mouse strains. Bafilomycins were also inhibitory towards cultures of concanavalin A- or lipopolysaccharide-activated murine spleen cells, and inhibited the mitogen-induced differentiation of B lymphocytes into immunoglobulin-secreting plasma cells. Corresponding results were obtained in human cell cultures. A hydrolysis product of the bafilomycin molecule was inactive. Bafilomycin also inhibited the growth of various lymphoid cell lines, the B cell line BCL1, the macrophage cell lines J774 and P338D1, and the T cell line EL4. The sensitivity of the tumor cell lines increased when, simultaneously with bafilomycin, mitogens were applied to the cell cultures. The immunosuppressive action of cyclosporin A could be enhanced by bafilomycin, which could be of importance for the elucidation of the molecular mechanism of T cell suppression, and for applied medical research.

    Topics: Animals; Anti-Bacterial Agents; B-Lymphocytes; Cell Division; Cell Line; Chemical Phenomena; Chemistry; Cyclosporins; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Lactones; Lymphocyte Activation; Lymphocytes; Lymphoma; Macrolides; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitogens; T-Lymphocytes; Tumor Cells, Cultured

1988